Literature DB >> 1516264

Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects.

T Hara1, S Kuriyama, H Kiyohara, Y Nagase, M Matsumoto, T Seya.   

Abstract

We have established an ELISA for determination of membrane cofactor protein (MCP, CD46) both solubilized from cell membranes and released in body fluids. In this assay, mouse MoAbs against MCP, M177 and M160 whose epitopes were different, were used as capture and detection antibodies, respectively. The NP-40 concentration in samples for MCP to be measured must be less than 0.05%. The detection limit of this MCP assay was 0.5 ng. The assay was used to quantify solubilized membrane MCP, and soluble MCP in normal human plasma, serum, urine, saliva, tears, and seminal fluid, and culture media of tumour cell lines. Soluble MCP was barely detected in the conditioned media of the cell lines. The levels of sMCP in plasma and serum were 10-60 ng/ml and that in tears, 0-50 ng/ml. Seminal fluid contained about 10-fold more soluble MCP than serum. Soluble MCP was not detectable by this assay in the other body fluids, suggesting that their MCP levels were less than the detection limit, if any.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516264      PMCID: PMC1554474          DOI: 10.1111/j.1365-2249.1992.tb06986.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

3.  The effect of epitope density and antibody affinity on the ELISA as analysed by monoclonal antibodies.

Authors:  A M Lew
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

4.  C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement.

Authors:  T Seya; S Nagasawa; J P Atkinson
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

5.  Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.

Authors:  M Matsumoto; Y Sugita; T Seya
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

6.  Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.

Authors:  S H Yoon; D T Fearon
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

Review 7.  Fc receptors and immunoglobulin binding factors.

Authors:  W H Fridman
Journal:  FASEB J       Date:  1991-09       Impact factor: 5.191

8.  Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.

Authors:  D M Lublin; K E Coyne
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins.

Authors:  D M Lublin; M K Liszewski; T W Post; M A Arce; M M Le Beau; M B Rebentisch; L S Lemons; T Seya; J P Atkinson
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  21 in total

1.  Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE).

Authors:  M Kawano; T Seya; I Koni; H Mabuchi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

Review 3.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

4.  Engineering of recombinant soluble CD46: an inhibitor of complement activation.

Authors:  D Christiansen; J Milland; B R Thorley; I F McKenzie; P L Mottram; L J Purcell; B E Loveland
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF).

Authors:  E Cocuzzi; L B Szczotka; W G Brodbeck; D S Bardenstein; T Wei; M E Medof
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

6.  Crystal structure of two CD46 domains reveals an extended measles virus-binding surface.

Authors:  J M Casasnovas; M Larvie; T Stehle
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

Review 7.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

8.  Identification and quantification of complement regulator CD46 on normal human tissues.

Authors:  R W Johnstone; B E Loveland; I F McKenzie
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

Review 9.  CD46 plasticity and its inflammatory bias in multiple sclerosis.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-01-26       Impact factor: 4.291

10.  CD46 Contributes to the severity of group A streptococcal infection.

Authors:  Lena Lövkvist; Hong Sjölinder; Rahma Wehelie; Helena Aro; Anna Norrby-Teglund; Laura Plant; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.